日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RETRACTION: Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice

撤稿:抗抵抗素中和抗体可减轻阿霉素诱导的小鼠心脏损伤

Markers, Disease

RETRACTION: Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer

撤稿:长链非编码RNA AFAP1-AS1通过miR-155-5p/FGF7轴促进细胞增殖和转移,并预测胃癌预后不良

Markers, Disease

RETRACTION: HuR Promotes the Progression of Gastric Cancer through Mediating CDC5L Expression

撤稿:HuR通过调控CDC5L表达促进胃癌进展

Markers, Disease

RETRACTION: Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer

撤稿:Nesfatin-1/Nucleobindin-2 是一种有效的预后标志物,并能增强膀胱癌细胞的增殖、迁移和侵袭能力

Markers, Disease

RETRACTION: MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma

撤稿:MCOLN1促进增殖并预测胰腺导管腺癌患者预后不良

Markers, Disease

RETRACTION: Kinesin Family Member 18A (KIF18A) Contributes to the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells In Vitro and In Vivo

撤稿:驱动蛋白家族成员18A (KIF18A) 在体外和体内均促进肺腺癌细胞的增殖、迁移和侵袭

Markers, Disease

RETRACTION: AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion

撤稿:AK4通过促进细胞增殖和侵袭来促进HER2阳性乳腺癌的进展

Markers, Disease

RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer

撤稿:PTK7表达增加是宫颈癌的恶性因素

Markers, Disease

RETRACTION: KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo

撤稿:KIF5A在体外和体内均能促进膀胱癌细胞增殖

Markers, Disease

RETRACTION: Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

撤稿:鉴定铁死亡相关基因预后特征和 HSF1 用于逆转子宫癌肉瘤的阿霉素和吉西他滨耐药性

Markers, Disease